QR has carved a niche for itself in the Chinese pharmaceutical industry, built trust among customers and business partners by its high quality products and service, and taken responsibility for the utmost care of patients, clients, and the well-being of the society. We are a leading developer, manufacturer and trusted supplier of finished dosage forms （FDFs） and Active Pharmaceutical Ingredients （APIs）. QR is dedicated in drug research and development in the fields of liver disease, cardiovascular, digesion, anti-fungal,and respiratory diseases. We are undertaking strategic transformation from traditional management to an international resource integrating research organization based on big data.
QR has always been committed to becoming a multinational enterprise both in professionalism and infrastructure to keep our growth. Therefore, we are willing to cooperate with domestic and international enterprise for a win-win future. For further information and potential collaboration, please contact us at email@example.com.
Guided by our global customers' needs, we are continually developing and expanding our range of quality Finished Dosage Forms (FDFs), Active Pharmaceutical Ingredients (APIs) and intermediates.
R & D Center
QR Shanghai R&D Center
Founded in 2004 with 30 staff;A virtual drug research platform focusing on new drug discovery, currently with 4 projects under development.
QR Wuhan R&D Center
Founded in 2009 with 80 staff;A Wuhan based new drug R &D center with 8 projects, 1 under Phase I clinical research,2 INDs under submission, and more to come.
Founded in 2015 with over 100 staff;CMC research center with project lifecycle management built on data integrity, currently with over 30 ongoing projects.